IL2 and neoplasm: For this particular aim, we used two different strategies: firstly, we addressed activating receptors responsible for NK cell stimulation triggered by an interaction of NK cells with their corresponding tumor antigen TKD in the presence of pro-inflammatory cytokines (IL-2).